Study Stopped
Slow accrual.
Comparison of Cyanoacrylate Tissue Adhesive and Suture for Closure of Cardiac Device Pockets
Prospective Comparison of Cyanoacrylate Tissue Adhesive (Dermabond) and Suture (Vicryl) for Closure of Cardiac Device Pockets
1 other identifier
interventional
103
1 country
1
Brief Summary
The purpose of this study is to determine whether cyanoacrylate tissue adhesive is as effective as polyglactin 910 suture for surgical closure of cardiac device pockets.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 5, 2008
CompletedFirst Posted
Study publicly available on registry
May 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2009
CompletedResults Posted
Study results publicly available
December 29, 2010
CompletedDecember 29, 2010
December 1, 2010
1 year
May 5, 2008
October 5, 2010
December 1, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reported Here Are the Number of Participants With Devices That Developed Infection
Within 3 months after surgery.
Study Arms (2)
Adhesive
EXPERIMENTALCyanoacrylate tissue adhesive.
Suture
ACTIVE COMPARATORPolyglactin 910 suture.
Interventions
Skin closure will be performed with cyanoacrylate tissue adhesive.
Skin closure will be performed with polyglactin 910 suture.
Eligibility Criteria
You may qualify if:
- Scheduled for implantation of a pacemaker or ICD in the deltopectoral region at Mayo Clinic Hospital in Phoenix.
You may not qualify if:
- Allergy to one of the closure materials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Phoenix, Arizona, 85054, United States
MeSH Terms
Conditions
Results Point of Contact
- Title
- Gregory Altemose MD
- Organization
- Mayo Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
Gregory Altemose, M.D.
Mayo Clinic
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 5, 2008
First Posted
May 7, 2008
Study Start
May 1, 2008
Primary Completion
May 1, 2009
Study Completion
May 1, 2009
Last Updated
December 29, 2010
Results First Posted
December 29, 2010
Record last verified: 2010-12